Gain Therapeutics, Inc. — All Filings
217 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-8
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | OWNERSHIP DOCUMENT | 0001104659-26-035403 | Mar 26, 2026 | Mar 24, 2026 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-26-035400 | Mar 26, 2026 | Mar 24, 2026 |
| 10-K | 10-K | 0001104659-26-035188 | Mar 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001104659-26-035174 | Mar 26, 2026 | — |
| 8-K | FORM 8-K | 0001104659-26-029968 | Mar 18, 2026 | — |
| 8-K | FORM 8-K | 0001104659-26-009747 | Feb 3, 2026 | — |
| 8-K | FORM 8-K | 0001104659-25-122353 | Dec 18, 2025 | — |
| S-8 | FORM S-8 | 0001104659-25-118118 | Dec 3, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-116947 | Nov 28, 2025 | — |
| 424B5 | 424B5 | 0001104659-25-116944 | Nov 28, 2025 | — |
| 10-Q | 10-Q | 0001104659-25-110347 | Nov 12, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001104659-25-110343 | Nov 12, 2025 | — |
| S-3/A | S-3/A | 0001104659-25-108472 | Nov 7, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-099343 | Oct 14, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-098376 | Oct 9, 2025 | Oct 6, 2025 |
| 8-K | FORM 8-K | 0001104659-25-097153 | Oct 6, 2025 | — |
| 10-Q | 10-Q | 0001558370-25-011220 | Aug 12, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001558370-25-011218 | Aug 12, 2025 | — |
| 424B5 | 424B5 | 0001104659-25-068532 | Jul 17, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-068530 | Jul 17, 2025 | Jul 15, 2025 |
| 424B5 | 424B5 | 0001104659-25-068103 | Jul 15, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-064145 | Jun 30, 2025 | — |
| 4 | 4 | 0001641172-25-016541 | Jun 25, 2025 | Jun 24, 2025 |
| 4 | — | 0001641172-25-016535 | Jun 25, 2025 | Jun 24, 2025 |
| 4 | 4 | 0001641172-25-016540 | Jun 25, 2025 | Jun 24, 2025 |
| 4 | — | 0001641172-25-016537 | Jun 25, 2025 | Jun 24, 2025 |
| 4 | 4 | 0001641172-25-016539 | Jun 25, 2025 | Jun 24, 2025 |
| 4 | — | 0001641172-25-016536 | Jun 25, 2025 | Jun 24, 2025 |
| 4 | — | 0001641172-25-016538 | Jun 25, 2025 | Jun 24, 2025 |
| 8-K | FORM 8-K | 0001104659-25-062162 | Jun 24, 2025 | — |
| S-3 | S-3 | 0001104659-25-053619 | May 28, 2025 | — |
| 10-Q | 10-Q | 0001558370-25-007747 | May 14, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001558370-25-007744 | May 14, 2025 | — |
| ARS | ARS | 0001558370-25-005837 | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0001558370-25-005832 | Apr 29, 2025 | — |
| DEF 14A | DEF 14A | 0001558370-25-005829 | Apr 29, 2025 | Jun 24, 2025 |
| PRE 14A | PRE 14A | 0001558370-25-004958 | Apr 17, 2025 | Jun 24, 2025 |
| 8-K | FORM 8-K | 0001104659-25-033797 | Apr 10, 2025 | — |
| 10-K | 10-K | 0001558370-25-003823 | Mar 27, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001558370-25-003807 | Mar 27, 2025 | — |
| 4 | — | 0001493152-25-011179 | Mar 21, 2025 | Mar 20, 2025 |
| 4 | — | 0001493152-25-011175 | Mar 21, 2025 | Mar 20, 2025 |
| 8-K | FORM 8-K | 0001104659-25-010148 | Feb 6, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-003801 | Jan 15, 2025 | Jan 8, 2025 |
| 4 | — | 0001493152-25-001281 | Jan 7, 2025 | Jan 6, 2025 |
| 8-K | FORM 8-K | 0001104659-25-001711 | Jan 7, 2025 | Jan 6, 2025 |
| 8-K | FORM 8-K | 0001104659-24-131084 | Dec 23, 2024 | — |
| 10-Q | 10-Q | 0001558370-24-015709 | Nov 14, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0001558370-24-015705 | Nov 14, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-110287 | Oct 21, 2024 | — |